Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
0.8120
+0.0402 (5.21%)
At close: Mar 31, 2026, 4:00 PM EDT
0.8300
+0.0180 (2.22%)
Pre-market: Apr 1, 2026, 7:20 AM EDT
Senti Biosciences Market Cap
Senti Biosciences has a market cap or net worth of $25.29 million as of April 1, 2026. Its market cap has decreased by -72.12% in one year.
Market Cap
25.29M
Enterprise Value
37.45M
1-Year Change
-72.12%
Ranking
Category
Stock Price
$0.81
Market Cap Chart
Since May 26, 2021, Senti Biosciences's market cap has decreased from $256.04M to $25.29M, a decrease of -90.12%. That is a compound annual growth rate of -37.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 20.29M | -25.79% |
| Dec 31, 2025 | 27.34M | 69.76% |
| Dec 31, 2024 | 16.11M | -45.22% |
| Dec 29, 2023 | 29.40M | -52.46% |
| Dec 30, 2022 | 61.84M | -78.72% |
| Dec 31, 2021 | 290.53M | 13.47% |
| May 26, 2021 | 256.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vistagen Therapeutics | 22.56M |
| Barinthus Biotherapeutics | 22.47M |
| Curis | 22.21M |
| Neuphoria Therapeutics | 22.10M |
| Outlook Therapeutics | 21.77M |
| Marker Therapeutics | 21.68M |
| Passage Bio | 20.47M |
| VYNE Therapeutics | 19.70M |